# Semprae Laboratories

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/semprae-laboratories

- Industry: Consumer Services
- Headquarters: Saddle Brook, US
- Website: www.semprae.com
- Total disclosed funding: $3.1M
- Latest round: Series A (Jan 1, 2010)
- Investors on record: 2

## About

Semprae Laboratories, Inc is dedicated to advancing women's sexual wellness through innovative products, particularly focusing on enhancing intimate experiences.Semprae Laboratories, Inc specializes in the development of sexual wellness products. Founded in 1996 in Saddle Brook, US, the company has undergone a strategic acquisition by Innovus Pharmaceuticals in December 2013. The firm has successfully completed 4 deals to date, and raised a total of USD 4.10 mn in funding. The latest funding round, which amounted to USD 4.10 mn, was backed by Quaker Partners Management and Versant Ventures.The flagship product, Zestra®, is designed to enhance women's sexual wellness by increasing arousal and enhancing sexual sensation. This product utilizes a patented blend of botanical oils and extracts, scientifically formulated to support women's intimate experiences. Zestra® is clinically tested and marketed to women in both the United States and Europe, emphasizing improvements in sexual satisfaction and intimacy.Zestra® drives revenue primarily through direct-to-consumer sales via an online platform, offering both individual purchases and a subscription service for regular deliveries. This model focuses on building long-term customer relationships, backed by a 100% satisfaction guarantee and a 45-day return policy. Specific pricing details for Zestra® products have not been disclosed, but the strategy indicates an emphasis on value-driven offerings to enhance customer retention in the sexual wellness sector.Semprae Laboratories is focused on developing new products aimed at enhancing women's sexual health, with anticipated launches in upcoming years. The company plans to expand its market presence in additional regions within Europe and Asia by 2025. Recent funding from the USD 4.10 mn round will support these product development initiatives and market expansion strategies.

## Funding rounds

- Series A, Jan 1, 2010, $3.1M — Quaker Partners Management, BR Partners

## Investors

- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series A
- BR Partners (https://capitalatlas.ai/funds/br-partners) — Series A